Mohammed, A., Janakiram, N. B., Li, Q., Madka, V., Ely, M., Lightfoot, S., . . . Rao, C. V. (2010). EGFR inhibitor gefitinib prevents progression of pancreatic lesions to carcinoma in a conditional LSL-Kras(G12D/+) transgenic mice model.

Mohammed, Altaf, Naveena B. Janakiram, Qian Li, Venkateshwar Madka, Misty Ely, Stan Lightfoot, Howard Crawford, Vernon E. Steele, và Chinthalapally V. Rao. EGFR Inhibitor Gefitinib Prevents Progression of Pancreatic Lesions to Carcinoma in a Conditional LSL-Kras(G12D/+) Transgenic Mice Model. 2010.

Mohammed, Altaf, et al. EGFR Inhibitor Gefitinib Prevents Progression of Pancreatic Lesions to Carcinoma in a Conditional LSL-Kras(G12D/+) Transgenic Mice Model. 2010.